摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-chloro-N-[1-[3-ethyl-2-[3-(4-methylpiperazin-1-yl)phenoxy]pyridin-4-yl]propyl]naphthalene-2-sulfonamide | 1110733-44-2

中文名称
——
中文别名
——
英文名称
5-chloro-N-[1-[3-ethyl-2-[3-(4-methylpiperazin-1-yl)phenoxy]pyridin-4-yl]propyl]naphthalene-2-sulfonamide
英文别名
——
5-chloro-N-[1-[3-ethyl-2-[3-(4-methylpiperazin-1-yl)phenoxy]pyridin-4-yl]propyl]naphthalene-2-sulfonamide化学式
CAS
1110733-44-2
化学式
C31H35ClN4O3S
mdl
——
分子量
579.163
InChiKey
VHKOEDQFOWPQHX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.7
  • 重原子数:
    40
  • 可旋转键数:
    9
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    83.2
  • 氢给体数:
    1
  • 氢受体数:
    7

文献信息

  • INHIBITOR OF BINDING OF S1P1
    申请人:Ono Naoya
    公开号:US20100234594A1
    公开(公告)日:2010-09-16
    A compound represented by formula (I) or a pharmaceutically acceptable salt thereof: (wherein Y 1 represents a nitrogen atom or a group represented by CR A , Y 2 represents a nitrogen atom or a group represented by CR B , Y 3 represents a nitrogen atom or a group represented by CR C , R A , R B and R C , which may be the same or different, each represent a hydrogen atom, etc. (excluding the case where Y 1 is CR A , Y 2 is CR B and Y 3 is CR C ), X represents an oxygen atom, etc., R 1 represents a C 1 -C 6 alkyl group, etc., R 2 represents a C 1 -C 6 alkyl group, etc., R 3 represents an optionally substituted phenyl group, etc., R 4 represents a hydrogen atom, etc., and R 5 represents an optionally substituted phenyl group, etc.) has an inhibitory effect on the binding between S1P and its receptor Edg-1(S1P 1 ), and is useful as a therapeutic agent for autoimmune diseases, rheumatoid arthritis, asthma, atopic dermatitis, rejection after organ transplantation, cancer, retinopathy, psoriasis, osteoarthritis, or age-related macular degeneration, etc.
  • US8048898B2
    申请人:——
    公开号:US8048898B2
    公开(公告)日:2011-11-01
查看更多